Jaime Merchan, MD, discusses the background and findings from the LITESPARK-013 trial of belzutifan for the treatment of patients with advanced clear cell renal cell carcinoma.

The two strategies, used to reduce renal, brain, and heart injury after surgery, were ineffective, but the story isn’t done.

This includes production for the four planned DehydraTECH formulation Study arms and clinical repackaging of the commercially available Rybelsus® comparator tablets for the Study control arm as ...

The reason for this, Dr. Primack explains, “Is because the dose of the injectable form achieves higher blood levels and therefore better appetite control." Rybelsus is the current oral ...

Does DehydraTECH processing of pure semaglutide evidence reduced side effects during daily dosing for 12 weeks, as DehydraTECH processing of Rybelsus® seemed to achieve in a prior human study ...

The capacity of household teaspoons ranges from 1.5 mL to 9 mL, potentially leading to errors in dosing. There are few studies evaluating alternative measuring devices. Objective: To assess adult ...

Nephrology is specialty of medicine concerned with kidney physiology, kidney disease, the treatment of kidney problems and renal replacement therapy. Systemic conditions that affect the kidneys (e ...

Dosing a statin (rosuvastatin) every other day (EOD) may provide significant lipoprotein changes while avoiding common adverse effects in this statin-intolerant population. Objective: To determine ...

This includes production for the four planned DehydraTECH formulation Study arms and clinical repackaging of the commercially available Rybelsus ... First Dose ("FPFD") Study milestone could ...